Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Aligos Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ALGS.
You can purchase shares of Aligos Therapeutics (NASDAQ:ALGS) through any online brokerage.
Other companies in Aligos Therapeutics’s space includes: Barinthus Biotherapeutics (NASDAQ:BRNS), FibroGen (NASDAQ:FGEN), OS Therapies (AMEX:OSTX), CollPlant Biotechnologies (NASDAQ:CLGN) and ABVC BioPharma (NASDAQ:ABVC).
Aligos Therapeutics has a consensus price target of $20.50.
The stock price for Aligos Therapeutics (NASDAQ: ALGS) is $4.2 last updated April 11, 2025 at 7:44 PM EDT.
There are no upcoming dividends for Aligos Therapeutics.
Aligos Therapeutics’s Q1 earnings are confirmed for Tuesday, May 6, 2025.
There is no upcoming split for Aligos Therapeutics.
Aligos Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.